References:
Agency for Healthcare Research and Quality, (n.d.). The Academy | Integrating Behavioral Health & Primary Care. https://integrationacademy.ahrq.gov/?_gl=1*gir6hb*_ga*MTczOTAxMjU5LjE3MzE1MzE4MzU.*_ga_45NDTD15CJ*MTczMTUzMTg3MC4xLjEuMTczMTUzMTg3MC42MC4wLjA
Bell, J. R., Butler, B., Lawrance, A., Batey, R., & Salmelainen, P. (2009). Comparing overdose mortality associated with methadone and buprenorphine treatment. Drug and alcohol dependence, 104(1-2), 73–77. https://doi.org/10.1016/j.drugalcdep.2009.03.020
Kosten, T. R., & George, T. P. (2002). The neurobiology of opioid dependence: implications for treatment. Science & practice perspectives, 1(1), 13–20. https://doi.org/10.1151/spp021113
Brown, R. L., & Rounds, L. A. (1995). Conjoint screening questionnaires for alcohol and other drug abuse: criterion validity in a primary care practice. Wisconsin medical journal, 94(3), 135–140.
Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022. MMWR Recomm Rep 2022;71(No. RR-3):1–95. DOI: http://dx.doi.org/10.15585/mmwr.rr7103a1
Giglio, R.E., Li, G. & DiMaggio, C.J, (2015). Effectiveness of bystander naloxone administration and overdose education programs: a meta-analysis. Inj. Epidemiol. 2, 10. https://doi.org/10.1186/s40621-015-0041-8
North Carolina General Assembly, (2023). Bills| House. NC CSRS Session Law 2023-65 Part XI Section 11.1 G.S. 90-113.73 . https://www.ncleg.gov/EnactedLegislation/Statutes/PDF/BySection/Chapter_90/GS_90-113.73.pdf
North Carolina Department of Health and Human Services, (n.d.). Overdose Epidemic. Opioid Overdose and Misuse Prevention Summit 2017. https://www.ncdhhs.gov/about/department-initiatives/overdose-epidemic
North Carolina Department of Public Health, (2021). CORE Overdose Slides| 2021 Data Year. North Carolina Department of Health and Human Services, Injury and Violence Prevention Branch. https://injuryfreenc.dph.ncdhhs.gov/datasurveillance/overdose.htm
North Carolina Department of Public Health, (2021). The NC Opioid and Substance Use Action Plan Data Dashboard. North Carolina Department of Health and Human Services. https://www.ncdhhs.gov/opioid-and-substance-use-action-plan-data-dashboard
North Carolina Department of Public Health, (2023). NC Safer Syringe Initiative Annual Report, 2022-2023. North Carolina Department of Health and Human Services. https://www.ncdhhs.gov/divisions/public-health/north-carolina-safer-syringe-initiative
North Carolina Medical Board, (n.d.). Understanding the Stop Act [Internet]. https://www.ncmedboard.org/images/uploads/article_images/The_STOP_Act_summary.6.30.2017.pdf
North Carolina Medical Board (n.d.). NC Controlled Substances Reporting System Gabapentin FAQ for Practitioners [Internet]. https://www.ncmedboard.org/images/uploads/other_pdfs/Gabapentin_FAQ_Sheet_for_Practitioners_Final.pdf
The Medical Letter June 5, 2017. 5(1522):89 . https://secure.Medicalletter.org/TML-article-1522a
Webster, L. R., & Webster, R. M. (2005). Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain medicine (Malden, Mass.), 6(6), 432–442. https://doi.org/10.1111/j.1526-4637.2005.00072.x
Resources:
• https://injuryfreenc.shinyapps.io/OpioidActionPlan/
• https://www.ncdhhs.gov/opioid-epidemic
• http://www.naloxonesaves.org/
• https://www.ncdhhs.gov/divisions/public-health/north-carolina-safer-syringeinitiative
• www.PreventRxAbuse.org
• https://www.gahec.org/uploads/Controlled-Sub-Workbook.pdf
• https://www.samhsa.gov/medication-assisted-treatment